|
Primary target group for influenza vaccination
|
Children
|
|
Age of vaccination
|
From 6 months of age, with special attention to the 6-60 month age group
|
|
Method of vaccine delivery
|
To fit within the existing vaccination schedule in the first and second year of life
|
|
Vaccination routine
|
Annual vaccination. For the first year of vaccination, all children should receive two doses with minimum interval of 4 weeks according to the manufacturer's recommendations. In the second year, children should receive a single dose of seasonal vaccine.
|
| |
For children aged between 6 and 35 months 0.25 mL doses are administered, equivalent to half the adult dose
|
|
Commonly reported reactions following vaccination
|
Mild soreness, redness, and swelling at injection site, fever, and aches. These symptoms usually begin soon after the injection, and last 1-2 days
|
|
Safety concerns
|
No safety concerns have been identified with the use of trivalent inactivated influenza vaccines with the exception that individuals with allergy to egg products should avoid immunisation
|
